{
  "pmcid": "12449959",
  "sha256": "0a945c1372bd99b276b9039b11dcbe64099c33a9938f5d3c60e17bfeb9f2a087",
  "timestamp_utc": "2025-11-09T15:42:46.313870+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 9.894231513743712,
    "reading_ease": 43.05846947993291,
    "word_count": 287
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "multicenter retrospective study"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "All 194 patients were divided into CS (94 patients) and DCB (100 patients) groups"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the midterm efficacy of CS and DCB procedures in patients with FPO."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary end point was primary patency at 24 months"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "All 194 patients were divided into CS (94 patients) and DCB (100 patients) groups"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "the CS used (hazard ratio [HR], 0.54 [95% CI, 0.32–0.91], P =0.021)"
      },
      "Harms": {
        "score": 1,
        "evidence": "major adverse events"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 10,
    "max_score": 25
  }
}